(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are HAVILA SHIPPING, ULTIMOVACS, and POLIGHT.

Financial Asset	Price	Change	Updated (EST)
HAVILA SHIPPING (HAVI.OL)	3.40	17.24%	2024-09-09 12:40:23
ULTIMOVACS (ULTI.OL)	2.59	14.6%	2024-09-09 12:44:06
POLIGHT (PLT.OL)	4.17	12.57%	2024-09-09 12:42:22
SOFINA (SOF.BR)	239.80	8.8%	2024-09-09 12:21:27
FLEXDEAL (FLEXD.LS)	4.64	8.41%	2024-09-09 12:23:11
MEDIA CAPITAL (MCP.LS)	1.40	7.69%	2024-09-09 12:23:36
OCEANTEAM (OTS.OL)	0.90	7.66%	2024-09-09 12:41:47
ADOCIA (ADOC.PA)	5.84	6.96%	2024-09-09 12:44:59
ELOPAK (ELO.OL)	43.00	6.18%	2024-09-09 12:25:49
ENSURGE MICROPOWER (ENSU.OL)	1.21	5.84%	2024-09-09 12:25:53

The three biggest losers today are NEW SOURCES ENERGY, ATLANTIC SAPPHIRE, and ALAN ALLMAN.

Financial Asset	Price	Change	Updated (EST)
NEW SOURCES ENERGY (NSE.AS)	0.01	-17.65%	2024-09-09 12:03:02
ATLANTIC SAPPHIRE (ASA.OL)	0.52	-13.31%	2024-09-09 12:24:45
ALAN ALLMAN (AAA.PA)	6.60	-8.97%	2024-09-09 12:45:20
VOW (VOW.OL)	2.60	-7.14%	2024-09-09 12:44:16
MOTORK (MTRK.AS)	5.40	-6.9%	2024-09-09 12:02:55
BERGENBIO (BGBIO.OL)	8.90	-6.41%	2024-09-09 12:25:02
ITERA (ITERA.OL)	10.25	-6.39%	2024-09-09 12:40:39
TEKNA HOLDING (TEKNA.OL)	4.84	-5.84%	2024-09-09 12:43:54
SEADRILL (SDRL.OL)	400.20	-4.94%	2024-09-09 12:43:02
MEDISTIM (MEDI.OL)	175.00	-4.89%	2024-09-09 12:41:07

Winners today

1. HAVILA SHIPPING (HAVI.OL)

17.24% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of vessels, including anchor handling vessels, platform supply vessels, rescue recovery vessel, and subsea vessels. Its subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. In addition, the company offers renewable energy services comprising of cable repair, trenching and ploughing, mooring and towing, and daughter craft operations, and transport of equipment and good services. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING jumping 17.24% to €3.40 on Monday while Oslo Børs Benchmark Index_GI jumped 0.49% to €1,392.67.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr0.17.

PE Ratio

HAVILA SHIPPING has a trailing twelve months price to earnings ratio of 20. Meaning, the purchaser of the share is investing kr20 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.13%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAVILA SHIPPING’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for HAVILA SHIPPING is 205577 which is 289.77% above its average volume of 52743.

Revenue Growth

Year-on-year quarterly revenue growth declined by 24.7%, now sitting on 405.18M for the twelve trailing months.

Moving Average

HAVILA SHIPPING’s value is way under its 50-day moving average of kr5.68 and way under its 200-day moving average of kr5.55.

More news about HAVILA SHIPPING.

2. ULTIMOVACS (ULTI.OL)

14.6% Price Change

Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ULTIMOVACS rising 14.6% to €2.59 on Monday while Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67.

Earnings Per Share

As for profitability, ULTIMOVACS has a trailing twelve months EPS of kr-5.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.69%.

Volatility

ULTIMOVACS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.79%, a negative 2.16%, and a positive 3.75%.

ULTIMOVACS’s highest amplitude of average volatility was 5.79% (last week), 4.41% (last month), and 3.75% (last quarter).

More news about ULTIMOVACS.

3. POLIGHT (PLT.OL)

12.57% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT jumping 12.57% to €4.17 on Monday while Oslo Børs Benchmark Index_GI jumped 0.49% to €1,392.67.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.09%.

Moving Average

POLIGHT’s worth is above its 50-day moving average of kr3.79 and way under its 200-day moving average of kr8.28.

More news about POLIGHT.

4. SOFINA (SOF.BR)

8.8% Price Change

Sofina Société Anonyme is a private equity and venture capital firm specializing in direct and fund of funds investments. Within direct investments, it specializes in growth capital, early, startup, later stages, mature, emerging growth, mid venture, late venture and LBO investments. The firm primarily invests in portfolio of companies that engages in digital transformation, consumer & retail, education, healthcare, energy and services, e-commerce, consumer goods, digital, satellite operations, industry, finance companies, and financial services worldwide. It also invests in the media, communications, insurance, property development sectors. The firm typically invests in European based companies with a global exposure, and it also has a particular focus on companies based in Western Europe and Asia such as in India, China and South East Asia and also in the United States. It invests between €20million ($21.67million) and €300 million ($339.2 million) in companies with an enterprise value between €250 million ($282.7 million) and €4500 million ($5088.41 million) in minority investments. The firm seeks to invest between €20 million (21.67 million) and €100 million ($107 million) in fast growing business. It seeks equity investment between €5 million ($5.35million) and €50 million (54.18 million) in venture and growth capital funds. It invests in privately owned and listed companies. It invests in private companies to support growth, finance acquisitions, give liquidity to existing shareholders/families, support sales processes, and make minority investment alongside shareholders controlling shareholders and in listed companies for replacement of existing shareholder, long term support of controlling shareholders, and delisting. Within fund of funds, the firm focuses on private equity, venture capital and growth equity funds, and selected relationships in buyout and special situations. It also manages funds in the fields of private equity funds. It typically invests in the US, Europe and Asia, and also concentrates on emerging markets. The firm prefers to hold a minority ownership equity in its portfolio companies and also seeks board seat. The firm also prefers majority stake and co-invests. It typically holds its investments for ten to twelve years. Sofina Société Anonyme was founded in 1898 and is based in Brussels, Belgium with additional offices in Luxembourg and Singapore.

BEL 20 ended the session with SOFINA rising 8.8% to €239.80 on Monday, after three successive sessions in a row of gains. BEL 20 rose 1.67% to €4,240.57, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, SOFINA has a trailing twelve months EPS of €12.72.

PE Ratio

SOFINA has a trailing twelve months price to earnings ratio of 18.85. Meaning, the purchaser of the share is investing €18.85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.62%.

Yearly Top and Bottom Value

SOFINA’s stock is valued at €239.80 at 22:40 EST, higher than its 52-week high of €231.80.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SOFINA’s stock is considered to be oversold (<=20).

Moving Average

SOFINA’s value is way above its 50-day moving average of €214.54 and way above its 200-day moving average of €215.49.

Volume

Today’s last reported volume for SOFINA is 75551 which is 252.82% above its average volume of 21413.

More news about SOFINA.

5. FLEXDEAL (FLEXD.LS)

8.41% Price Change

Flexdeal Simfe S.A. operates as a securities investment company. It also offers GEN, a management and business program for entrepreneurs, managers and managers of small and medium enterprises to improve personal management skills, and access financial control and planning tools. In addition, the company provides FLEXSAÚDE platform, to evaluate, analyze, and monitor indicators of mental health and psychological wellbeing in the workplace. The company was incorporated in 2014 and is based in Barcelos, Portugal. Flexdeal Simfe S.A. is a subsidiary of Flexdeal Participações S.A.

PSI ended the session with FLEXDEAL jumping 8.41% to €4.64 on Monday while PSI rose 0.83% to €6,774.89.

Earnings Per Share

As for profitability, FLEXDEAL has a trailing twelve months EPS of €0.23.

PE Ratio

FLEXDEAL has a trailing twelve months price to earnings ratio of 20.17. Meaning, the purchaser of the share is investing €20.17 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.85%.

Volatility

FLEXDEAL’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.34%, a negative 4.40%, and a positive 8.80%.

FLEXDEAL’s highest amplitude of average volatility was 5.34% (last week), 12.18% (last month), and 8.80% (last quarter).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 20, 2024, the estimated forward annual dividend rate is 0.09 and the estimated forward annual dividend yield is 1.99%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 3.16M for the twelve trailing months.

More news about FLEXDEAL.

6. MEDIA CAPITAL (MCP.LS)

7.69% Price Change

Grupo Media Capital, SGPS, S.A. engages in the production and broadcasting of television and radio programs, and production and operation of cinematographic and video graphic activities in Portugal and internationally. It operates through Television, Radio & Entertainment, Audiovisual Production, and Others segments. The company broadcasts TVI, TVI 24, TVI Ficção, TVI Internacional, TVI Reality, and TVI Player channels. It is involved in the production, realization, and distribution of audiovisuals; and production of television programs for broadcasting in Portuguese language. The company operates Rádio Comercial, m80, Cidade FM, Smooth FM, and Vodafone FM radio stations; and 14 digital radios. It also operates iol.pt, an online directory of classified information; recording, publishing, events production, and artist management; and provides agency services for artists and promotion of events. The company is also involved in the provision of production support services; realization and development of television contents, cinema, and audiovisual works, as well as other related services; production of phonograms, audiovisual, and multimedia; purchase and sale of records and other items; and acquisition and distribution of cinematographic rights. Grupo Media Capital, SGPS, S.A. was incorporated in 1992 and is headquartered in Barcarena, Portugal.

PSI ended the session with MEDIA CAPITAL rising 7.69% to €1.40 on Monday while PSI jumped 0.83% to €6,774.89.

Volume

Today’s last reported volume for MEDIA CAPITAL is 300 which is 9.89% above its average volume of 273.

Moving Average

MEDIA CAPITAL’s worth is way above its 50-day moving average of €1.13 and way higher than its 200-day moving average of €1.19.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEDIA CAPITAL’s stock is considered to be oversold (<=20).

More news about MEDIA CAPITAL.

7. OCEANTEAM (OTS.OL)

7.66% Price Change

Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 7.66% to €0.90 on Monday while Oslo Børs Benchmark Index_GI jumped 0.49% to €1,392.67.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.26.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.84%.

More news about OCEANTEAM.

8. ADOCIA (ADOC.PA)

6.96% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 6.96% to €5.84 on Monday while CAC 40 jumped 0.99% to €7,425.26.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

Yearly Top and Bottom Value

ADOCIA’s stock is valued at €5.84 at 22:40 EST, way under its 52-week high of €16.16 and way higher than its 52-week low of €5.11.

Revenue Growth

Year-on-year quarterly revenue growth declined by 69.1%, now sitting on 6.05M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADOCIA’s stock is considered to be overbought (>=80).

More news about ADOCIA.

9. ELOPAK (ELO.OL)

6.18% Price Change

Elopak ASA manufactures and supplies paper-based packaging solutions for liquid food in Europe, the Middle East, Africa, Asia, the Americas, and internationally. It offers Pure-Pak cartons for chilled and aseptic liquid food; common roll fed aseptic carton; D-PAK cartons for non food products for personal and home care; and filling equipment. It also offers standard flexo, super flexo, UV-flexo, and offset litho printing services, as well as digital print proofs and machine print proofs on paper board. Further, it provides machines and equipment through spare part webshop. Elopak ASA was founded in 1957 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELOPAK jumping 6.18% to €43.00 on Monday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67, after five successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, ELOPAK has a trailing twelve months EPS of kr3.07.

PE Ratio

ELOPAK has a trailing twelve months price to earnings ratio of 14.01. Meaning, the purchaser of the share is investing kr14.01 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.46%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 1.1B for the twelve trailing months.

Moving Average

ELOPAK’s value is way above its 50-day moving average of kr22.63 and way above its 200-day moving average of kr23.47.

Yearly Top and Bottom Value

ELOPAK’s stock is valued at kr43.00 at 22:40 EST, way above its 52-week high of kr26.00.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 50% and a negative 89.4%, respectively.

More news about ELOPAK.

10. ENSURGE MICROPOWER (ENSU.OL)

5.84% Price Change

Ensurge Micropower ASA provides energy storage solutions for wearable devices, connected sensors, and other applications in Norway. The company offers solid-state lithium battery technology that enables it to produce rechargeable batteries. It serves hearables, medical and sports/fitness wearables, and home and industrial devices sectors. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 5.84% to €1.21 on Monday, after five successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67, after five sequential sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-2.91.

Volatility

ENSURGE MICROPOWER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.56%, a negative 0.99%, and a positive 3.41%.

ENSURGE MICROPOWER’s highest amplitude of average volatility was 3.56% (last week), 3.83% (last month), and 3.41% (last quarter).

Yearly Top and Bottom Value

ENSURGE MICROPOWER’s stock is valued at kr1.21 at 22:40 EST, way under its 52-week high of kr4.19 and way higher than its 52-week low of kr0.10.

More news about ENSURGE MICROPOWER.

Losers Today

1. NEW SOURCES ENERGY (NSE.AS)

-17.65% Price Change

New Sources Energy N.V. focuses on developing, operating, exploiting, and investing in projects that generates energy using renewable energy sources. The company was formerly known as Management Share NV and changed its name to New Sources Energy N.V. on July 2011. New Sources Energy N.V. is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with NEW SOURCES ENERGY sliding 17.65% to €0.01 on Monday, after five successive sessions in a row of losses. AEX-Index jumped 1.03% to €888.31, after four consecutive sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, NEW SOURCES ENERGY has a trailing twelve months EPS of €-0.01.

Volume

Today’s last reported volume for NEW SOURCES ENERGY is 100000 which is 60.24% above its average volume of 62406.

More news about NEW SOURCES ENERGY.

2. ATLANTIC SAPPHIRE (ASA.OL)

-13.31% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 13.31% to €0.52 on Monday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67, after five sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-25.66.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Yearly Top and Bottom Value

ATLANTIC SAPPHIRE’s stock is valued at kr0.52 at 22:40 EST, way below its 52-week low of kr4.50.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

More news about ATLANTIC SAPPHIRE.

3. ALAN ALLMAN (AAA.PA)

-8.97% Price Change

Alan Allman Associates, together with its subsidiaries, engages in the provision of consulting services in Canada, France, Belgium, Luxembourg, Switzerland, and Singapore. The company offers technology consulting in the areas, including cybersecurity, cloud, data management, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, commercial intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, process consulting, etc. The company was incorporated in 1954 and is based in Issy-les-Moulineaux, France.

CAC 40 ended the session with ALAN ALLMAN falling 8.97% to €6.60 on Monday, after three sequential sessions in a row of losses. CAC 40 rose 0.99% to €7,425.26, after four successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, ALAN ALLMAN has a trailing twelve months EPS of €0.13.

PE Ratio

ALAN ALLMAN has a trailing twelve months price to earnings ratio of 50.77. Meaning, the purchaser of the share is investing €50.77 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.5%.

More news about ALAN ALLMAN.

4. VOW (VOW.OL)

-7.14% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. The company operates through Industrial Solutions, Maritime Solutions, and Aftersales segments. The Industrial Solutions segment offers and designs plants for processing biomass, food products, and industry residues. The Maritime Solution segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables chemicals; and tailor-made service and maintenance programs. In addition, it offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. Further, the company develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. It serves cruise, aquaculture, and landbased industries, as well as utilities. The company has a strategic partnership agreement with Repsol, S.A. for addressing the pressing issue of plastic waste; SAS IMPROVE for research and development of technological solutions; and Circon Energy, for equipment supply carbon refinery projects. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW sliding 7.14% to €2.60 on Monday while Oslo Børs Benchmark Index_GI jumped 0.49% to €1,392.67.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr-1.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.4%.

More news about VOW.

5. MOTORK (MTRK.AS)

-6.9% Price Change

MotorK plc, together with its subsidiaries, provides software-as-a-service for the automotive retail industry in Italy, Spain, France, Germany, and the Benelux Union. The company offers a combination of automotive SaaS products and digital solutions to the digital lead generation, management, and nurturing process; and technology and software solutions for car manufacturers, dealers, and service centers. The company also provides WebSparK, a web platform for traffic acquisition and lead generation performance; LeadSparK, a CRM platform to support the activities of car dealerships and automotive manufacturers; and StockSparK, an automotive stock management platform. MotorK plc was incorporated in 2010 and is based in Milan, Italy.

AEX-Index ended the session with MOTORK dropping 6.9% to €5.40 on Monday while AEX-Index jumped 1.03% to €888.31.

Earnings Per Share

As for profitability, MOTORK has a trailing twelve months EPS of €-0.28.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.52%.

Moving Average

MOTORK’s worth is below its 50-day moving average of €5.89 and way higher than its 200-day moving average of €4.68.

Yearly Top and Bottom Value

MOTORK’s stock is valued at €5.40 at 22:40 EST, way below its 52-week high of €6.10 and way above its 52-week low of €1.80.

More news about MOTORK.

6. BERGENBIO (BGBIO.OL)

-6.41% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO sliding 6.41% to €8.90 on Monday while Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-15.16.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Moving Average

BERGENBIO’s worth is way higher than its 50-day moving average of kr0.13 and way higher than its 200-day moving average of kr4.18.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.98%, a negative 0.99%, and a positive 2.82%.

BERGENBIO’s highest amplitude of average volatility was 4.32% (last week), 2.94% (last month), and 2.82% (last quarter).

Volume

Today’s last reported volume for BERGENBIO is 474750 which is 66.83% above its average volume of 284561.

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr8.90 at 22:40 EST, way under its 52-week high of kr13.03 and way higher than its 52-week low of kr0.08.

More news about BERGENBIO.

7. ITERA (ITERA.OL)

-6.39% Price Change

Itera ASA, together with its subsidiaries, develops and operates digital solutions for businesses and organizations in Norway, Sweden, Ukraine, Denmark, Czech Republic, Iceland, Poland, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company provides a range of services in the strategy and consulting, customer experience, and technology and cloud transformation areas. It serves banking and insurance, energy and utilities, industry and manufacturing, health and public services, technology and communication, and products and retail industries. The company was founded in 1989 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ITERA falling 6.39% to €10.25 on Monday while Oslo Børs Benchmark Index_GI jumped 0.49% to €1,392.67.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.59.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 17.37. Meaning, the purchaser of the share is investing kr17.37 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.36%.

Yearly Top and Bottom Value

ITERA’s stock is valued at kr10.25 at 22:40 EST, way under its 52-week high of kr14.35 and higher than its 52-week low of kr10.00.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 23, 2024, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 3.65%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 868.66M for the twelve trailing months.

Volume

Today’s last reported volume for ITERA is 47479 which is 118.19% above its average volume of 21760.

More news about ITERA.

8. TEKNA HOLDING (TEKNA.OL)

-5.84% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING sliding 5.84% to €4.84 on Monday while Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.1.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.36%.

Volatility

TEKNA HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.31%, a negative 1.68%, and a positive 4.00%.

TEKNA HOLDING’s highest amplitude of average volatility was 3.51% (last week), 3.77% (last month), and 4.00% (last quarter).

More news about TEKNA HOLDING.

9. SEADRILL (SDRL.OL)

-4.94% Price Change

Seadrill Limited provides offshore contract drilling services to the oil and gas industry worldwide. The company owns and operates drill ships, semi-submersible rigs, and jack-up rigs for operations in shallow and ultra-deep-water in benign and harsh environments. It serves oil super-majors, state-owned national oil companies, and independent oil and gas companies. Seadrill Limited was formerly known as Seadrill 2021 Limited. The company was founded in 2005 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with SEADRILL sliding 4.94% to €400.20 on Monday, after four consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67, after five successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, SEADRILL has a trailing twelve months EPS of kr67.28.

PE Ratio

SEADRILL has a trailing twelve months price to earnings ratio of 5.95. Meaning, the purchaser of the share is investing kr5.95 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.51%.

More news about SEADRILL.

10. MEDISTIM (MEDI.OL)

-4.89% Price Change

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with MEDISTIM sliding 4.89% to €175.00 on Monday while Oslo Børs Benchmark Index_GI rose 0.49% to €1,392.67.

Earnings Per Share

As for profitability, MEDISTIM has a trailing twelve months EPS of kr5.7.

PE Ratio

MEDISTIM has a trailing twelve months price to earnings ratio of 30.7. Meaning, the purchaser of the share is investing kr30.7 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.31%.

Yearly Top and Bottom Value

MEDISTIM’s stock is valued at kr175.00 at 22:40 EST, way below its 52-week high of kr237.00 and way above its 52-week low of kr146.50.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 533.17M for the twelve trailing months.

More news about MEDISTIM.

Stay up to date with our winners and losers daily report